Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Biktarvy2.95B44.06%
Other728M10.89%
Veklury555M8.30%
Descovy426M6.37%
Sofosbuvir/Velpatasvir405M6.06%
Genvoya403M6.03%
Yescarta380M5.68%
Odefsey310M4.64%
Trodelvy309M4.62%
Vemlidy225M3.36%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States19.44B71.68%
Europe4.31B15.89%
Other international3.37B12.42%
